Experts Call on World Leaders to Commit to a Global Plan of Attack on COVID at Summit
More Than 60 Leading Organizations Across Civil Society, Academia, Philanthropy, Health, and Social Enterprise Define a 6-Point Plan to End the Global COVID-19 Crisis SEATTLE, Sept. 20, 2021 /PRNewswire/ -- This week, hosted by the United States, world leaders will gather virtually for the Global COVID-19 Summit: Ending The Pandemic And Building Back Better. According to a group of...
India Ministry of Health and Family Welfare Approves Exablate Neuro Focused Ultrasound Platform
HAIFA, Israel and MIAMI, Fla., Sept. 20, 2021 /PRNewswire/ -- Insightec®, a global healthcare company focused on transforming patient care, announced its incisionless neurosurgery platform, the Exablate® 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO), part of the Ministry of Health and Family Welfare of India. The Exablate 4000 (Exablate...
Terumo celebrates 100-year anniversary in Asia with an eye to the future
SINGAPORE, Sept. 20, 2021 /PRNewswire/ -- Terumo, a global leader in medical technology, celebrates its centenary in Asia. From humble beginnings as a thermometer manufacturer in 1921, and the first company in 1963 to create disposable syringes in Japan, the company has been providing medical solutions for the healthcare community and quality...
Appealing Data of CARsgen Therapeutics’ CAR-T (CT041) in Advanced Gastric Cancer Presented at ESMO
SHANGHAI, Sept. 20, 2021 /PRNewswire/ -- On September 19, 2021, CARsgen Therapeutics (stock code: 2171.HK) disclosed the latest progress of the investigator-initiated trial (IIT) of Claudin18.2 (CLDN18.2) CAR-T (CT041) for the treatment of digestive system tumors. Results of this trial have been orally presented at the European Society of Medical Oncology Congress 2021 (ESMO 2021). The presenter was Dr....
Illumina reaffirms commitment to the National Project of Bio Big Data in Korea
MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in Korea has selected Illumina technology for the second pilot project in their effort to work towards establishing a national digital library on health and genome data by 2028. The multi-ministerial project is overseen by the Ministry of Health...
Qynapse Unveils Strategic Rebrand To Support Accelerated Growth And New Corporate Vision
BOSTON, Sept. 20, 2021 /PRNewswire/ -- Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, unveils a full rebrand including new logo and a complete website redesign, intended to better reflect the company's strategic vision, focus and its commitment to excellence. The company...
New Zealand’s Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated
Growing concern that people are reluctant to see their doctor about troubling symptoms during current uncertain period. This follows last year's lockdown which saw a decline in diagnosis of cancer across Aotearoa. Around 9,000 New Zealanders die of cancer every year. New campaign launched today encourages people to get unusual and persistent symptoms checked by their...
CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors...
SUZHOU, China, Sept. 19, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative cancer immunotherapies and precision medicines, today announced the preliminary results from the phase Ib study of anti-CTLA-4 mAb CS1002 in combination with anti-PD-1 mAb CS1003 in patients with advanced solid tumors (Study CS1002-101;NCT03523819) at...
2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar
SHANGHAI, Sept. 18, 2021 /PRNewswire/ -- The 24th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) will be held online and in-person from 25th to 29th September 2021. In this meeting, Henlius will release 4 study results of 2 products to be commercialized, the novel anti-PD-1 mAb serplulimab and the bevacizumab biosimilar HLX04. The study results will all...
Global Kidney Innovation Summit Accelerates International Consortium
Patient Needs and Insights Drive New Era of Global Kidney Research, Discovery, and Personalized Treatments WASHINGTON, Sept. 18, 2021 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the USA, and its strategic partners at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) continue to make a unique impact in the international battle against...
